Black Diamond Therapeutics, Inc.
BDTX • NASDAQ
Black Diamond Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark A. Velleca, with a market cap of $116.3M.
Market Cap$116.3M
Employees54.0
CEOMark A. Velleca
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Black Diamond Therapeutics, Inc. FAQ
Common questions about Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $30.0M.
Black Diamond Therapeutics, Inc. has approximately 54 employees.